GB1388582A - 3-amino-2,3-dihydroquinobenzoxa or thia zepine derivatives - Google Patents

3-amino-2,3-dihydroquinobenzoxa or thia zepine derivatives

Info

Publication number
GB1388582A
GB1388582A GB2610072A GB2610072A GB1388582A GB 1388582 A GB1388582 A GB 1388582A GB 2610072 A GB2610072 A GB 2610072A GB 2610072 A GB2610072 A GB 2610072A GB 1388582 A GB1388582 A GB 1388582A
Authority
GB
United Kingdom
Prior art keywords
alkyl
compounds
reacting
amino
hnr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2610072A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of GB1388582A publication Critical patent/GB1388582A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/18—[b, e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/14—[b, e]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GB2610072A 1971-06-24 1972-06-05 3-amino-2,3-dihydroquinobenzoxa or thia zepine derivatives Expired GB1388582A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15655771A 1971-06-24 1971-06-24

Publications (1)

Publication Number Publication Date
GB1388582A true GB1388582A (en) 1975-03-26

Family

ID=22560065

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2610072A Expired GB1388582A (en) 1971-06-24 1972-06-05 3-amino-2,3-dihydroquinobenzoxa or thia zepine derivatives

Country Status (8)

Country Link
US (1) US3784548A (cg-RX-API-DMAC7.html)
JP (2) JPS5724356B1 (cg-RX-API-DMAC7.html)
CA (1) CA978524A (cg-RX-API-DMAC7.html)
CH (2) CH553810A (cg-RX-API-DMAC7.html)
DE (1) DE2229311A1 (cg-RX-API-DMAC7.html)
FR (1) FR2143423B1 (cg-RX-API-DMAC7.html)
GB (1) GB1388582A (cg-RX-API-DMAC7.html)
HU (1) HU163951B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966762A (en) * 1974-06-03 1976-06-29 Sterling Drug Inc. N-[6,7]-Dihydroindolo[1,7-ab][1]benzazepin-2-yl)methyl/phthalimide

Also Published As

Publication number Publication date
HU163951B (cg-RX-API-DMAC7.html) 1973-11-28
CA978524A (en) 1975-11-25
JPS5724356B1 (cg-RX-API-DMAC7.html) 1982-05-24
DE2229311A1 (de) 1972-12-28
CH553809A (fr) 1974-09-13
FR2143423A1 (cg-RX-API-DMAC7.html) 1973-02-02
US3784548A (en) 1974-01-08
CH553810A (fr) 1974-09-13
JPS56135487A (en) 1981-10-22
FR2143423B1 (cg-RX-API-DMAC7.html) 1975-10-17

Similar Documents

Publication Publication Date Title
DE69010375T2 (de) Protease-Hemmer.
ATE14423T1 (de) Hydroxamsaeurederivate vom typ der mannich-basen mit verbesserter biologischer verfuegbarkeit von nicht-steroiden entzuendungshemmern, verfahren zur herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzung.
ES417012A2 (es) Mejoras introducidas en el objeto de la patente principal, num. 399.057.
SG15689G (en) Substituted acyl derivatives of 1,2,3,4-tetrahydroiso-quinoline-3-carboxylic acids,salts thereof,pharmaceutical compositions containing the derivatives or salts,and the production of the same
ATE63124T1 (de) Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
GB1446141A (en) Cinnamamides and hydrocinnamides and processes for their preparation
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
FI904850A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 24-homo-D-vitamiinijohdannaisten valmistamiseksi
ES455089A1 (es) Procedimiento de preparacion de nuevas oximas derivadas del acido 7-aminotioazolil-acetamido-cefalosporanico.
GB1046506A (en) Guanidine compounds and process for their manufacture
US2520264A (en) Substituted 3, 1-benz-2, 3, 4, 5-tetrahydroazepines
GB1459065A (en) Therapeutic thiophene derivatives
ZA807176B (en) Alkenyl-substituted thienylalkanecarboxylic acids and derivatives thereof, methods for preparation of these compounds, and pharmaceutical compositions thereof
GB1285400A (en) Esters of substituted anthranilic acid
US2324013A (en) Amino-substituents of sulphanil-amide derivatives
EP0395528A3 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
DE3483881D1 (de) 1,3-dioxan-4-ylalkensaeure.
IE41444L (en) Pharmaceutical compositions containing cinnamamides
ES8202017A1 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
DE3863214D1 (de) Glutaminsaeurederivate, ihre salze, verfahren zu ihrer herstellung, verwendung als arzneimittel und diese enthaltende zusammensetzungen.
IE41219L (en) Aralkyl esters of aminoalkanoic acids
JPS6485954A (en) Novel cinnamamide derivative and medicine containing said derivative
ES435604A1 (es) Procedimiento para la preparacion de derivados de indolila- cetilaminoacidos.
GB1040555A (en) ª‡-alkylidene-sulfonylphenoxy acetic acids, derivatives thereof, and pharmaceutical compositions containing them
ATE41771T1 (de) Z-omega-thio-substituierte-2-(2,2dimethylcyclopropancarboxamido)-2-alkensaeuren, verfahren zu ihrer herstellung und diese enthaltende zusammensetzung.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee